Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | GAA | P10253 | 3/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.40 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.40 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.40 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.40 |
| ▸ | HTT | P42858 | 2/20 | 0.38 |
| ▸ | PAX8 | Q06710 | 1/20 | 0.38 |
| ▸ | PRCP | P42785 | 1/20 | 0.32 |
| ▸ | GHSR | Q92847 | 3/20 | 0.32 |
| ▸ | PDE5A | O76074 | 1/20 | 0.32 |
| ▸ | SOAT2 | O75908 | 1/20 | 0.32 |
| ▸ | SOAT1 | P35610 | 1/20 | 0.32 |
| ▸ | VDR | P11473 | 2/20 | 0.31 |
| ▸ | CCR5 | P51681 | 2/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2867325 | 1.00 | MEN1 (0.41) | MEN1KMT2AGAALMNACYP3A4 | |
| SCHEMBL4404002 | 0.91 | MEN1 (0.37) | MEN1KMT2AGAALMNACYP3A4 | |
| SCHEMBL14952860 | 0.91 | MEN1 (0.37) | MEN1KMT2AGAALMNACYP3A4 | |
| SCHEMBL14952771 | 0.89 | MEN1 (0.36) | MEN1KMT2AGAALMNACYP3A4 | |
| SCHEMBL13033905 | 0.89 | SOAT1 (0.40) | MEN1KMT2AGAALMNACYP3A4 | |
| SCHEMBL30415527 | 0.89 | SOAT1 (0.40) | MEN1KMT2AGAALMNACYP3A4 | |
| SCHEMBL30038822 | 0.87 | HRH3 (0.39) | MEN1KMT2A | |
| SCHEMBL6440744 | 0.87 | HRH3 (0.39) | MEN1KMT2A | |
| SCHEMBL2869111 | 0.87 | HRH3 (0.39) | MEN1KMT2A | |
| SCHEMBL30436539 | 0.87 | HRH3 (0.39) | MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 33 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115536598-B | New synthesis method of 1, 4-dimethyl-2, 5-piperazine dione compound | 青岛科技大学 | 2024-04-02 | — | — | CN | claimed |
| CN-115536598-A | Novel synthesis method of 1,4-dimethyl-2,5-piperazinedione compound | 青岛科技大学 | 2022-12-30 | — | — | CN | claimed |
| US-9738685-B2 | Use of ruthenium complexes for preparing amides, polypeptides and cyclic dipeptides | YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) | 2017-08-22 | — | — | US | claimed |
| WO-2010030197-A1 | CONCENTRATION OF ALGAL BIOMASS | MILLER IAN JAMES (NZ) | 2010-03-18 | — | — | WO | claimed |
| CN-115536598-B | New synthesis method of 1, 4-dimethyl-2, 5-piperazine dione compound | 青岛科技大学 | 2024-04-02 | — | — | CN | disclosed |
| CN-115536598-A | Novel synthesis method of 1,4-dimethyl-2,5-piperazinedione compound | 青岛科技大学 | 2022-12-30 | — | — | CN | disclosed |
| EP-3443054-B1 | PROCESS FOR PRODUCING A COMBUSTIBLE PRODUCT | INDUSTRIAL CHEMICALS GROUP LTD (GB) | 2020-01-29 | — | — | EP | disclosed |
| EP-2629889-B1 | RUTHENIUM COMPLEXES AND THEIR USES IN PROCESSES FOR FORMATION AND/OR HYDROGENATION OF ESTERS, AMIDES AND DERIVATIVES THEREOF | YEDA RES & DEV (IL) | 2019-04-03 | — | — | EP | disclosed |
| EP-2629889-B1 | RUTHENIUM COMPLEXES AND THEIR USES IN PROCESSES FOR FORMATION AND/OR HYDROGENATION OF ESTERS, AMIDES AND DERIVATIVES THEREOF | YEDA RES & DEV (IL) | 2019-04-03 | — | — | EP | disclosed |
| US-9840479-B2 | Polyamine-fatty acid derived lipidoids and uses thereof | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2017-12-12 | — | — | US | disclosed |
| EP-3231856-A1 | COMBUSTIBLE PRODUCT | Industrial Chemicals Group Limited (GB) | 2017-10-18 | — | — | EP | disclosed |
| US-9738685-B2 | Use of ruthenium complexes for preparing amides, polypeptides and cyclic dipeptides | YEDA RESEARCH AND DEVELOPMENT CO. LTD. (IL) | 2017-08-22 | — | — | US | disclosed |
| US-20110295006-A1 | CYCLIC DIPEPTIDES AS FEED ADDITIVES | EVONIK DEGUSSA GMBH (DE) | 2011-12-01 | — | — | US | disclosed |
| WO-2011126383-A1 | HYDROTHERMAL TRANSFORMATION OF MICROALGAE THROUGH CATALYSIS WITH CLAYS AND ALUMINOSILICATES | AQUAFLOW BIONOMIC CORPORATION LIMITED (NZ) | 2011-10-13 | — | — | WO | disclosed |
| WO-2011126382-A1 | HYDROTHERMAL TRANSFORMATION OF MICROALGAE THROUGH METAL-BASE CATALYSIS | AQUAFLOW BIONOMIC CORPORATION LIMITED (NZ) | 2011-10-13 | — | — | WO | disclosed |
| US-20110232344-A1 | CONCENTRATION OF ALGAL BIOMASS | AQUAFLOW BIONOMIC CORPORATION LIMITED (NZ) | 2011-09-29 | — | — | US | disclosed |
| US-7745392-B2 | Multi-valent guanidinium compounds for enhancing molecular translocation across cellular membranes and epithelial tissues | NITTO DENKO CORPORATION (JP) | 2010-06-29 | — | — | US | disclosed |
| WO-2010030197-A1 | CONCENTRATION OF ALGAL BIOMASS | MILLER IAN JAMES (NZ) | 2010-03-18 | — | — | WO | disclosed |
| US-20070078078-A1 | Multi-valent guanidinium compounds for enhancing molecular translocation across cellular membranes and epithelial tissues | NITTO DENKO CORPORATION (JP) | 2007-04-05 | — | — | US | disclosed |
| US-20050077648-A1 | Solution casting method and polymer film | FUJIFILM CORPORATION (JP) | 2005-04-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110295006-A1 | CYCLIC DIPEPTIDES AS FEED ADDITIVES | VIP, AADAT, ARGLU1 | MEN1 2911/4885KMT2A 1037/4885GAA 4782/4885 |
| US-20070078078-A1 | Multi-valent guanidinium compounds for enhancing molecular translocation across cellular membranes and epithelial tissues | GLS, FABP2, GOLIM4 | MEN1 4047/4885KMT2A 4516/4885GAA 263/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.